Overview

Pharmacological Treatment of Rett Syndrome With Statins

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This is a phase 2 , open label, dose escalating study of Lovastatin in Rett syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Montefiore Medical Center
Collaborator:
Rett Syndrome Research Trust
Treatments:
Dihydromevinolin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
L 647318
Lovastatin